Medicus Pharma Ltd. (MDCX)

NCM – Цена в реальном времени. Валюта: USD

0.33

-0.01 (-3.96%)

Рынок открыт: Aug 12, 2026, 2:02 PM EDT

0.35

+0.01 (2.00%)

Предыдущая сессия: Aug 11, 2026, 7:58 PM EDT

03.08.2026

Medicus Pharma CMO to lead Antev's Teverelix clinical programme

Medicus Pharma (NASDAQ:MDCX) announced it has put its chief medical officer in charge of UK subsidiary Antev Limited, consolidating leadership of the Teverelix clinical programme ahead of regulatory, late-stage development and partnering work. Dr Faisal Mehmud will become Antev's chief executive on August 30, while retaining his positions as Medicus chief medical officer and co-chairman of the subsidiary.

03.08.2026

Medicus Pharma Appoints Dr. Faisal Mehmud as Chief Executive Officer of Antev Limited, United Kingdom

Dr. Mehmud's appointment further aligns the scientific, clinical, regulatory and operational leadership of Antev Dr. Mehmud's appointment further aligns the scientific, clinical, regulatory and operational leadership of Antev

01.08.2026

Medicus Pharma targets Gorlin Syndrome with SkinJect - ICYMI

Medicus Pharma (NASDAQ:MDCX) earlier this week announced that the US Food and Drug Administration (FDA) has cleared the company's Phase 2b registration-enabling clinical trial for SkinJect in patients with Gorlin syndrome, representing an important regulatory milestone for its lead investigational asset. Speaking with Proactive, CEO Raza Bokhari said the FDA had approved the company's proposed study following discussions and feedback, allowing Medicus Pharma (NASDAQ:MDCX) to move ahead with a crossover registration study involving up to 50 patients.

Видео

No Data

There is no data to display

Пресс-релизы

03.08.2026

Medicus Pharma Ltd. (MDCX)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Medicus Pharma Ltd. (MDCX)

Medicus Pharma CMO to lead Antev's Teverelix clinical programme

Medicus Pharma Appoints Dr. Faisal Mehmud as Chief Executive Officer of Antev Limited, United Kingdom

Medicus Pharma targets Gorlin Syndrome with SkinJect - ICYMI

Видео

No Data

Пресс-релизы

Medicus Pharma Appoints Dr. Faisal Mehmud as Chief Executive Officer of Antev Limited, United Kingdom

Medicus Pharma CMO to lead Antev's Teverelix clinical programme

Medicus Pharma Appoints Dr. Faisal Mehmud as Chief Executive Officer of Antev Limited, United Kingdom

Medicus Pharma targets Gorlin Syndrome with SkinJect - ICYMI

Видео

No Data

Пресс-релизы

Medicus Pharma Appoints Dr. Faisal Mehmud as Chief Executive Officer of Antev Limited, United Kingdom

Search stocks

Medicus Pharma Ltd. (MDCX)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Medicus Pharma Ltd. (MDCX)

Medicus Pharma CMO to lead Antev's Teverelix clinical programme

Medicus Pharma Appoints Dr. Faisal Mehmud as Chief Executive Officer of Antev Limited, United Kingdom

Medicus Pharma targets Gorlin Syndrome with SkinJect - ICYMI

Видео

No Data

Пресс-релизы

Medicus Pharma Appoints Dr. Faisal Mehmud as Chief Executive Officer of Antev Limited, United Kingdom

Medicus Pharma CMO to lead Antev's Teverelix clinical programme

Medicus Pharma Appoints Dr. Faisal Mehmud as Chief Executive Officer of Antev Limited, United Kingdom

Medicus Pharma targets Gorlin Syndrome with SkinJect - ICYMI

Видео

No Data

Пресс-релизы

Medicus Pharma Appoints Dr. Faisal Mehmud as Chief Executive Officer of Antev Limited, United Kingdom